Mounting evidence suggests that age-related cognitive decline is caused not by nerve cell death, as it is in Alzheimer’s disease, but from a disruption in synapses, the structures that allow a nerve cell to transmit a signal to other nerve cells. Demonstrating these synaptic disruptions in the prefrontal cortex of the brain, and linking such disruptions to synaptic health, has been challenging for scientists—until now.
The creation of a trachea engineered from stem cells that can be transplanted in people with lung or airway diseases is being pioneered by physicians at St. Luke’s and Roosevelt Hospitals. The promising technology will be presented at the Society of Thoracic Surgeons 50th Annual Meeting in Orlando in late January by a team led by Faiz Bhora, MD, Director of Thoracic Surgical Oncology and Thoracic Surgery Research at St. Luke’s and Roosevelt Hospitals.
Tony-nominated actress Valisia LeKae used her voice to sing hit songs from the 1960s, recently starring as Diana Ross in “Motown: The Musical” on Broadway. Now, two months after receiving a diagnosis of ovarian cancer, and stepping down from her leading role to receive treatment at The Mount Sinai Hospital, Ms. LeKae is using her voice to speak about the importance of early cancer detection.
Are you interested in helping the Center for Excellence in Youth Education (CEYE) increase diversity in science and medicine by mentoring students in high school and college? If so, you would be joining the more than 100 Mount Sinai physicians, scientists, nurses, social workers, lab technicians, residents, and postdoctoral students who have invited students to shadow them in their jobs over the last two years. The students are selected after a competitive application process and must maintain a B average throughout the duration of the program. CEYE is sponsored by the Center for Multicultural and Community Affairs at Icahn School of Medicine at Mount Sinai. To learn more, contact Alyson Davis, MSW, at 212-241-7655 or email@example.com.
It was a “miracle on 125th Street” last December, when Cecil Williams, who is blind, temporarily lost consciousness and fell onto the subway tracks at the Harlem station with his loyal service dog Orlando close behind. Onlookers frantically summoned help. Together, the two survived in the space between the tracks as the train pulled in above them.
Suffering from cuts and bruises, and a laceration to his head, Mr. Williams was treated at St. Luke’s Hospital for nine days before being released. Orlando was always at his side.
The Mount Sinai Department of Radiation Oncology is now treating patients with superficial non-melanoma skin cancers such as squamous cell and basal cell carcinomas, and keloids, with a non-invasive and painless procedure, Superficial Radiotherapy. The procedure utilizes superficial x-rays that concentrate radiation dose on the skin surface. There are several advantages of using superficial radiation therapy to treat non-melanoma skin cancers and keloids, including:
Richard Rosen, MD, Vice Chair of the Department of Ophthalmology at New York Eye and Ear Infirmary, and a team of researchers in the Shelley and Steven Einhorn Clinical Research Center, are pioneering an imaging technology that enables them to see microscopic details of the retina and its finest blood vessels at a level not previously possible in patients with sight–threatening disease.
The Icahn School of Medicine at Mount Sinai, and National Jewish Health, the nation’s leading respiratory hospital, based in Denver, Colorado, have created a partnership to advance patient care and research in respiratory and related diseases. The Mount Sinai–National Jewish Health Respiratory Institute is expected to open on the Icahn School of Medicine campus in July.
The Mount Sinai Health System recently established the Mount Sinai Institute of Technology (MSIT), with a $5 million grant from the New York City Economic Development Corporation (NYCEDC). As part of Icahn School of Medicine at Mount Sinai, MSIT will train students to develop technology-based solutions that improve human health, and serve as an incubator for transformative, cost-effective discoveries.